A new multitargeted drug candidate in Alzheimer disease: 1,4-dihydropyridine-benzylidenhydrazon derived AChE inhibitor

SEVİN G., Alançay E., Yılmaz S., ALPTÜZÜN V., YETİK ANACAK G. Y.

Second WG Meeting COST ACTION CA15135, Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig), 15 - 16 Mart 2018

  • Yayın Türü: Bildiri / Özet Bildiri
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır